DaVita Inc. Files 8-K: Corporate Structure Update

TL;DR

DaVita filed an 8-K updating corporate info, including past names like Total Renal Care Holdings.

AI Summary

DaVita Inc. filed an 8-K on May 20, 2025, reporting on other events and financial statements. The filing details the company's corporate structure and historical name changes, including its previous names DaVita Healthcare Partners Inc. and Total Renal Care Holdings Inc. The report confirms DaVita Inc. is incorporated in Delaware with its principal executive offices located in Denver, Colorado.

Why It Matters

This filing provides an official update on DaVita Inc.'s corporate information, which is important for investors and stakeholders to ensure they have the most current details about the company's legal and historical structure.

Risk Assessment

Risk Level: low — The filing is a routine corporate update and does not contain information that suggests immediate financial risk or significant operational changes.

Key Players & Entities

• DAVITA INC. (company) — Registrant
• DaVita Healthcare Partners Inc. (company) — Former Company Name
• Total Renal Care Holdings Inc (company) — Former Company Name
• May 20, 2025 (date) — Date of Report
• Denver, CO 80202 (location) — Principal Executive Address

FAQ

From the Filing

0001206774-25-000368.txt : 20250520 0001206774-25-000368.hdr.sgml : 20250520 20250520090735 ACCESSION NUMBER: 0001206774-25-000368 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250520 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250520 DATE AS OF CHANGE: 20250520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 25966449 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva4487951-8k.htm CURRENT REPORT false 0000927066 0000927066 2025-05-20 2025-05-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       Form 8-K       CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): May 20, 2025         DAVITA INC. (Exact name of registrant as specified in its charter)       Delaware 1-14106   51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)         2000 16th Street Denver , CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)   ☐        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class:   Trading symbol(s):   Name of each exchange on which registered: Common Stock, $0.001 par value   DVA   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐         Item 8.01. Other Events.   On May 20, 2025, DaVita Inc. (the “Company”) issued a press release, made pursuant to Rule 135c promulgated under the Securi